Gingiva ve Alveolar Mukozanın Malign Neoplazmları

Abstract

Klinisyenler, enfektif, idiyopatik, enflamatuar, reaktif ve neoplastik değişiklikler gibi çeşitli etiyolojilerden kaynaklanabilen çeşitli oral lezyonlarla karşılaşırlar. Neoplastik değişiklikler diğer etkileyen durumlarla karşılaştırıldığında nadirdir, ancak ağız boşluğu tümörlerin ve tümör benzeri lezyonların en sık geliştiği alanlardan biridir ve hem non-odontojenik hem de odontojenik lezyonları içerir. Ağız mukozasını etkileyen hastalıklar çok çeşitlidir ve benign veya malign lezyonlardan oluşan geniş bir spektrumu kapsar. Doğru bir tanı koymak için, klinisyen kapsamlı bir klinik öykü almalı ve oral mukozal lezyonun yeri, boyutu, rengi ve morfolojisi gibi belirti ve semptomlar hakkında yeterli bilgiye sahip olmalıdır. Bu derlemenin amacı, dişeti ve alveolar mukozayı etkileyebilecek malign neoplazmların klinik, radyografik, mikroskobik ve tedavi yönlerini tanımlamaktır.

Keywords

• malign lezyonlar
• gingiva
• alveolar mukoza

Malign Neoplasms of Gingiva and Alveolar Mucosa

Abstract

Clinicians encounter a variety of oral lesions that can originate from various etiologies, such as from infective, idiopathic, inflammatory, reactive, and neoplastic changes. Neoplastic changes are rare compared with other affecting conditions, however, the oral cavity is one of the areas where tumors and tumor-like lesions most commonly develop and include both non-odontogenic and odontogenic lesions. Diseases affecting the oral mucosa are diverse and cover a broad spectrum of benign or malignant lesions. To make an accurate diagnosis, a clinician must take a comprehensive clinical history and have adequate information about the signs and symptoms, such as location, size, color, and morphology of the oral mucosal lesion. This review aims to describe the clinical, radiographic, microscopic, and treatment aspects of malign neoplasms that might affect the gingiva and alveolar mucosa.

Keywords

• malign lesions
• gingiva
• alveolar mucosa

References

1. 1. Schmidt CW. NTP nonneoplastic lesion atlas: a new tool for toxicologic pathology. Environ Health Perspect. 2014;122(3):A76-9. doi:10.1289/ehp.122-A76
2. 2. Vinay Kumar AKAJCA. Robbins Basic Pathology. In: Robbins Basic Pathology. 10th ed. Elsevier - Health Sciences Division; 2023:190.
3. 3. Jang SJ, Gardner JM, Ro JY. Diagnostic Approach and Prognostic Factors of Cancers. Adv Anat Pathol. 2011;18(2):165-172. doi:10.1097/PAP.0b013e31820cb39e
4. 4. Fowler CB. Benign and malignant neoplasms of the periodontium. Periodontol 2000. 1999;21(1):33-83. doi:10.1111/j.1600-0757.1999.tb00168.x
5. 5. Fitzsimonds ZR, Rodriguez-Hernandez CJ, Bagaitkar J, Lamont RJ. From Beyond the Pale to the Pale Riders: The Emerging Association of Bacteria with Oral Cancer. J Dent Res. 2020;99(6):604-612. doi:10.1177/0022034520907341
6. 6. Johnson NW, Jayasekara P, Amarasinghe AAHK. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000. 2011;57(1):19-37. doi:10.1111/j.1600-0757.2011.00401.x
7. 7. Melo BA de C, Vilar LG, Oliveira NR de, et al. Human papillomavirus infection and oral squamous cell carcinoma - a systematic review. Braz J Otorhinolaryngol. 2021;87(3):346-352. doi:10.1016/j.bjorl.2020.10.017
8. 8. Tsimplaki E, Argyri E, Xesfyngi D, Daskalopoulou D, Stravopodis DJ, Panotopoulou E. Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma. Anticancer Res. 2014;34(2):1021-1025.

9. 9. Pires FR, Ramos AB, Oliveira JBC de, Tavares AS, Luz PSR da, Santos TCRB dos. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single Oral Pathology service during an 8-year period. Journal of Applied Oral Science. 2013;21(5):460-467. doi:10.1590/1679-775720130317
10. 10. Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Res. 2020;9:229. doi:10.12688/f1000research.22941.1
11. 11. Al–Mahozi S, Salim Z, Malden NJ, Scully C, Lopes V. Tobacco habit-associated oral disease and the negative effects on surgical outcomes. Dent Update. 2017;44(11):1065-1070. doi:10.12968/denu.2017.44.11.1065
12. 12. Su Mun L, Wye Lum S, Kong Yuiin Sze G, et al. Association of Microbiome with Oral Squamous Cell Carcinoma: A Systematic Review of the Metagenomic Studies. Int J Environ Res Public Health. 2021;18(14):7224. doi:10.3390/ijerph18147224
13. 13. Duray A, Descamps G, Decaestecker C, et al. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope. 2012;122(7):1558-1565. doi:10.1002/lary.23298
14. 14. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer. Cancer Epidemiology, Biomarkers & Prevention. 2005;14(3):735-739. doi:10.1158/1055-9965.EPI-04-0546
15. 15. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant Analysis of Salivary Tumor Markers—A New Diagnostic Tool for Oral Cancer. Clinical Cancer Research. 2006;12(13):3979-3984. doi:10.1158/1078-0432.CCR-05-2412
16. 16. Elashoff D, Zhou H, Reiss J, et al. Prevalidation of Salivary Biomarkers for Oral Cancer Detection. Cancer Epidemiology, Biomarkers & Prevention. 2012;21(4):664-672. doi:10.1158/1055-9965.EPI-11-1093
17. 17. Imbesi Bellantoni M, Picciolo G, Pirrotta I, et al. Oral Cavity Squamous Cell Carcinoma: An Update of the Pharmacological Treatment. Biomedicines. 2023;11(4):1112. doi:10.3390/biomedicines11041112
18. 18. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843-850. doi:10.1002/hed.20279
19. 19. Zidar N, Gale N, Kojc N, et al. Cadherin–catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Archiv. 2008;453(3):267-274. doi:10.1007/s00428-008-0649-y
20. 20. Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity. Oral Surgery, Oral Medicine, Oral Pathology. 1980;50(6):523-534. doi:10.1016/0030-4220(80)90436-3
21. 21. Oktay M, Kokenek-Unal TD, Ocal B, Saylam G, Korkmaz MH, Alper M. Spindle Cell Carcinoma of the Tongue: A Rare Tumor in an Unusual Location. Patholog Res Int. 2011;2011:1-6. doi:10.4061/2011/572381
22. 22. Chang NJ, Kao DS, Lee LY, et al. Sarcomatoid carcinoma in head and neck: a review of 30 years of experience--clinical outcomes and reconstructive results. Ann Plast Surg. 2013;71 Suppl 1:S1-7. doi:10.1097/SAP.0000000000000069
23. 23. Feng L, Cai D, Muhetaer A, et al. Spindle cell carcinoma: the general demographics, basic clinico-pathologic characteristics, treatment, outcome and prognostic factors. Oncotarget. 2017;8(26):43228-43236. doi:10.18632/oncotarget.18017
24. 24. Yamazaki M, Maruyama S, Abé T, et al. Spindle cell squamous cell carcinoma exhibiting prominent neutrophil phagocytosis: a case report. J Med Case Rep. 2021;15(1):438. doi:10.1186/s13256-021-03066-z
25. 25. Santosh H, Nagaraj T, Saxena S, Biswas A, Pai S. Verrucous carcinoma: A clinicopathological study. Journal of Oral and Maxillofacial Pathology. 2019;23(2):303. doi:10.4103/jomfp.JOMFP_59_19
26. 26. Thompson LDR. Verrucous Squamous Cell Carcinoma. Ear Nose Throat J. 2021;100(5_suppl):540S-541S. doi:10.1177/0145561319871712
27. 27. Rodrigues-Fernandes CI, Arboleda LPA, Vargas PA, Lopes MA, Santos-Silva AR. Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia. Oral Oncol. 2021;116:105144. doi:10.1016/j.oraloncology.2020.105144
28. 28. Franklyn J, Janakiraman R, Tirkey AJ, Thankachan C, Muthusami J. Oral Verrucous Carcinoma: Ten Year Experience from a Tertiary Care Hospital in India. Indian Journal of Medical and Paediatric Oncology. 2017;38(04):452-455. doi:10.4103/ijmpo.ijmpo_153_16
29. 29. Thompson LDR. Laryngeal Dysplasia, Squamous Cell Carcinoma, and Variants. Surg Pathol Clin. 2017;10(1):15-33. doi:10.1016/j.path.2016.10.003
30. 30. Rekha KP, Angadi P V. Verrucous carcinoma of the oral cavity: a clinico-pathologic appraisal of 133 cases in Indians. Oral Maxillofac Surg. 2010;14(4):211-218. doi:10.1007/s10006-010-0222-0
31. 31. Ashok S, Damera S, Ganesh S, Karri R. Oral malignant melanoma. Journal of Oral and Maxillofacial Pathology. 2020;24(4):82. doi:10.4103/jomfp.JOMFP_5_19
32. 32. Zito PM, Brizuela M, Mazzoni T. Oral Melanoma.; 2023.
33. 33. Hashemi Pour M. Malignant melanoma of the oral cavity: A review of literature. Indian Journal of Dental Research. 2008;19(1):47. doi:10.4103/0970-9290.38932
34. 34. Astekar M, Choubey RR, Manjunatha BS, Gupta S. Oral malignant melanoma of alveolar ridge. BMJ Case Rep. 2019;12(5):e227456. doi:10.1136/bcr-2018-227456
35. 35. Barker BF, Carpenter WM, Daniels TE, et al. Oral muscosal melanomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1997;83(6):672-679. doi:10.1016/S1079-2104(97)90318-8
36. 36. Lambertini M, Patrizi A, Fanti PA, et al. Oral melanoma and other pigmentations: when to biopsy? Journal of the European Academy of Dermatology and Venereology. 2018;32(2):209-214. doi:10.1111/jdv.14574
37. 37. Gorsky M, Epstein JB. Head and neck and intra-oral soft tissue sarcomas. Oral Oncol. 1998;34(4):292-296.
38. 38. Patil G, Halawar S, Sagari S, Babannavar R, Purohit S. Embryonal rhabdomyosarcoma occurring on mandibular gingiva in an adult. J Clin Diagn Res. 2013;7(9):2088-2089. doi:10.7860/JCDR/2013/6008.3415
39. 39. Chi AC, Barnes JD, Budnick S, Agresta S V., Neville B. Rhabdomyosarcoma of the Maxillary Gingiva. J Periodontol. 2007;78(9):1839-1845. doi:10.1902/jop.2007.060454
40. 40. Tandon A, Sethi K, Singh AP. Oral Rhabdomyosarcoma: A review. J Clin Exp Dent. Published online 2012:e302-308. doi:10.4317/jced.50926
41. 41. Gordón-Núñez MA, Piva MR, Dos Anjos ED, Freitas RA. Orofacial rhabdomyosarcoma: report of a case and review of the literature. Med Oral Patol Oral Cir Bucal. 2008;13(12):E765-9.
42. 42. Maha O, Amina K, Laila H, Maria EL K, Mohamed EL K, Mohamed K. Rhabdomyosarcoma of the Tongue. Clinical Medical Image Library. 2019;5(3). doi:10.23937/2474-3682/1510135
43. 43. Fatahzadeh M, Schwartz RA. Oral Kaposi’s sarcoma: a review and update. Int J Dermatol. 2013;52(6):666-672. doi:10.1111/j.1365-4632.2012.05758.x
44. 44. Thieringer FM, Cede J, Glatz K, Roehling S, Stoeckle M, Leiggener CS. Oral Kaposi’s Sarcoma: A Case Report and Literature Review on Treatment Management. Craniomaxillofacial Trauma & Reconstruction Open. 2021;6:247275122110363. doi:10.1177/24727512211036328
45. 45. Oh JK, Weiderpass E. Infection and Cancer: Global Distribution and Burden of Diseases. Ann Glob Health. 2014;80(5):384. doi:10.1016/j.aogh.2014.09.013
46. 46. Meriem H, Bouhairi MEL, Ben Yahya I. Non HIV oral Kaposi Sarcoma: Rare case report literature review. Advances in Oral and Maxillofacial Surgery. 2022;6:100225. doi:10.1016/j.adoms.2021.100225
47. 47. Sakina G, Liew YT. Kaposi’s sarcoma of the palate. QJM: An International Journal of Medicine. 2022;114(12):896-897. doi:10.1093/qjmed/hcab264
48. 48. Cammarata-Scalisi F, Girardi K, Strocchio L, et al. Oral Manifestations and Complications in Childhood Acute Myeloid Leukemia. Cancers (Basel). 2020;12(6):1634. doi:10.3390/cancers12061634
49. 49. Quispe RA, Aguiar EM, de Oliveira CT, Neves ACX, Santos PS da S. Oral manifestations of leukemia as part of early diagnosis. Hematol Transfus Cell Ther. 2022;44(3):392-401. doi:10.1016/j.htct.2021.08.006
50. 50. Busjan R, Hasenkamp J, Schmalz G, Haak R, Trümper L, Ziebolz D. Oral health status in adult patients with newly diagnosed acute leukemia. Clin Oral Investig. 2018;22(1):411-418. doi:10.1007/s00784-017-2127-x
51. 51. Reenesh M, Munishwar S, Rath SK. Generalised Leukaemic Gingival Enlargement: a Case Report. J Oral Maxillofac Res. 2012;3(3). doi:10.5037/jomr.2012.3305
52. 52. Allareddy V, Prakasam S, Allareddy V, et al. Poor Oral Health Linked with Increased Risk of Infectious Complications in Adults with Leukemia. J Mass Dent Soc. 2015;64(3):38-42.
53. 53. Varun BR, Varghese NO, Sivakumar TT, Joseph AP. Extranodal Non-Hodgkin’s Lymphoma of the Oral Cavity: A Case Report. Iran J Med Sci. 2017;42(4):407-411.
54. 54. Kobler P, Borcic J, Zore IF, Nola M, Sertic D. Primary non-Hodgkin’s lymphoma of the oral cavity. Oral Oncology Extra. 2005;41(1):12-14. doi:10.1016/j.ooe.2004.10.002
55. 55. Silva TDB, Tavares Ferreira CB, Boehmer Leite G, de Menezes Pontes JR, Antunes HS. Oral manifestations of lymphoma: a systematic review. Ecancermedicalscience. 2016;10. doi:10.3332/ecancer.2016.665
56. 56. Manjunatha B, Nagarajappa D, Gowramma R, Tanveer A. Extranodal non-Hodgkin′s lymphoma presenting as gingival mass. J Indian Soc Periodontol. 2011;15(4):418. doi:10.4103/0972-124X.92584
57. 57. Aswath N, Balakrishnan C, Shyamsundar V, Thirrugnanamurthy S. Oral gingival metastasis: A diagnostic dilemma. Indian Journal of Dental Research. 2017;28(3):344. doi:10.4103/ijdr.IJDR_261_16
58. 58. Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. Journal of Oral Pathology & Medicine. 1993;22(9):385-390. doi:10.1111/j.1600-0714.1993.tb00128.x
59. 59. Cantero R, Diez L, Pérez JCG, et al. Gingival metastasis as first sign of a rectal cancer. Coloproctology. 1998;6(20):229-232.
60. 60. Nuyen BA, Tang CG. Gingival Metastasis: A Case Report and Literature Review. Perm J. 2016;20(1):71-73. doi:10.7812/TPP/15-057